DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Botox (Botulinum Toxin Type A) - Adverse Event Reports - Serious Event - Muscular Weakness

 



Index of reports > Cases resulting in a serious event (101) > Cases with Muscular Weakness (9)

Below is the selection of adverse event reports related to Botox (Botulinum Toxin Type A) that includes cases resulting in a serious event where reactions include muscular weakness.

Adverse event in receiving Botox (Botulinum Toxin Type A)

Reported by a physician from United States on 2007-10-24

Patient:

Adverse reactions / side effects: Abdominal Pain, Oral Intake Reduced, Weight Decreased, Dysphagia, Pneumonia Aspiration, Incorrect Dose Administered, Muscular Weakness, Asthenia

Adverse event resulted in: hospitalization

Suspect drug(s):
Botox
    Dosage: 1370 units, single
    Indication: Cerebral Palsy
    Start date: 2007-09-18
    End date: 2007-09-18

Botox
    Indication: Muscle Spasticity



Adverse event in male receiving Botox (Botulinum Toxin Type A)

Reported by a consumer/non-health professional from Denmark on 2007-10-18

Patient: male

Adverse reactions / side effects: Myalgia, Incorrect Route of Drug Administration, Activities of Daily Living Impaired, Muscular Weakness

Adverse event resulted in: disablity

Suspect drug(s):
Botox (Botulinum Toxin Type A)

Other drugs received by patient: Lyrica



Adverse event in male receiving Botox (Botulinum Toxin Type A)

Reported by a consumer/non-health professional from Norway on 2007-10-05

Patient: male

Adverse reactions / side effects: Dysphagia, Muscular Weakness

Adverse event resulted in: hospitalization

Suspect drug(s):
Botox (Botulinum Toxin Type A)

Other drugs received by patient: Enalapril Maleate; Enanton Depot SET; Allopur; Hydrochlorothiazide



Adverse event in female receiving Botox (Botulinum Toxin Type A)

Reported by a consumer/non-health professional from United States on 2007-07-25

Patient: female

Adverse reactions / side effects: Trismus, Drooling, Neck Pain, Muscular Weakness, Skin Burning Sensation, Eye Disorder, Muscle Spasms

Suspect drug(s):
Botox
    Dosage: unk, single
    Indication: Facial Spasm
    Start date: 2006-09-07
    End date: 2006-09-07

Botox
    Dosage: unk, single
    Indication: Headache
    Start date: 2006-09-22
    End date: 2006-09-22

Botox
    Dosage: unk, single
    Indication: Temporomandibular Joint Syndrome
    Start date: 2006-10-06
    End date: 2006-10-06



Adverse event in 2 year old female receiving Botox (Botulinum Toxin Type A)

Reported by a consumer/non-health professional from United States on 2007-06-02

Patient: 2 year old female, weighing 14.0 kg (30.8 pounds)

Adverse reactions / side effects: Dysphagia, Gastroenteritis Rotavirus, Muscular Weakness, Eyelid Ptosis, Botulism

Adverse event resulted in: hospitalization

Suspect drug(s):
Botox
    Dosage: 160 units, single
    Indication: Quadriparesis
    Start date: 2007-05-08
    End date: 2007-05-08

Botox

Botox

Other drugs received by patient: Keppra



Adverse event in 2 year old female receiving Botox (Botulinum Toxin Type A)

Reported by a consumer/non-health professional from United States on 2007-05-24

Patient: 2 year old female, weighing 14.0 kg (30.8 pounds)

Adverse reactions / side effects: Dysphagia, Muscular Weakness, Eyelid Ptosis, Botulism

Adverse event resulted in: hospitalization

Suspect drug(s):
Botox
    Dosage: 160 units, single
    Indication: Quadriparesis
    Start date: 2007-05-08
    End date: 2007-05-08

Botox

Botox



Adverse event in 40 year old female receiving Botox (Botulinum Toxin Type A)

Reported by a physician from South Africa on 2007-02-20

Patient: 40 year old female, weighing 65.0 kg (143.0 pounds)

Adverse reactions / side effects: Back Pain, Guillain-Barre Syndrome, Nausea, Hypotension, Muscular Weakness, Organ Failure, Brain Oedema, Dizziness, Pulmonary Oedema, Cytomegalovirus Infection, Respiratory Arrest, Ventricular Fibrillation, Cardiac Arrest, Muscle Spasms, Lung Injury

Adverse event resulted in: death, life threatening event, hospitalization

Suspect drug(s):
Botox
    Dosage: 22 units, single
    Indication: Skin Wrinkling
    Start date: 2006-07-27
    End date: 2006-07-27

Botox
    Dosage: 22 units, single
    Start date: 2006-10-25
    End date: 2006-10-25

Other drugs received by patient: Natrilix / 00340101 /; Diane



Adverse event in female receiving Botox (Botulinum Toxin Type A)

Reported by a consumer/non-health professional from United States on 2007-02-15

Patient: female, weighing 54.0 kg (118.8 pounds)

Adverse reactions / side effects: Muscle Atrophy, Pain, Skin Disorder, Muscular Weakness, Paralysis, Myalgia, Injection Site Reaction, Mastication Disorder

Adverse event resulted in: disablity

Suspect drug(s):
Botox (Botulinum Toxin Type A)



Adverse event in 36 year old female receiving Botox (Botulinum Toxin Type A)

Reported by a consumer/non-health professional from United States on 2007-01-17

Patient: 36 year old female

Adverse reactions / side effects: Trismus, Drooling, Neck Pain, Muscular Weakness, Skin Burning Sensation, Eye Disorder, Muscle Spasms

Suspect drug(s):
Botox
    Dosage: unk, single
    Indication: Facial Spasm
    Start date: 2006-09-07
    End date: 2006-09-07

Botox
    Dosage: unk, single
    Start date: 2006-09-22
    End date: 2006-09-22

Botox
    Dosage: unk, single
    Start date: 2006-10-06
    End date: 2006-10-06

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009